NCT00130884View on ClinicalTrials.gov

Peroral Levosimendan in Chronic Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

March 31, 2006

Conditions
Chronic Heart FailureHeart Diseases
Interventions
DRUG

levosimendan

Trial Locations (1)

00029

Helsinki University Central Hospital, Helsinki

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT00130884 - Peroral Levosimendan in Chronic Heart Failure | Biotech Hunter | Biotech Hunter